Karyopharm Therapeutics
KPTI
KPTI
129 hedge funds and large institutions have $340M invested in Karyopharm Therapeutics in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 30 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
16% less funds holding
Funds holding: 154 → 129 (-25)
58% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 43
Holders
129
Holding in Top 10
1
Calls
$1.03M
Puts
$515K
Top Buyers
| 1 | +$8.97M | |
| 2 | +$7.35M | |
| 3 | +$7.01M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$6.24M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$6M |
Top Sellers
| 1 | -$15M | |
| 2 | -$13.1M | |
| 3 | -$6.77M | |
| 4 |
CC
Commodore Capital
New York
|
-$6.58M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$6.55M |